195 related articles for article (PubMed ID: 28743784)
1. Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice.
Wehr MC; Hinrichs W; Brzózka MM; Unterbarnscheidt T; Herholt A; Wintgens JP; Papiol S; Soto-Bernardini MC; Kravchenko M; Zhang M; Nave KA; Wichert SP; Falkai P; Zhang W; Schwab MH; Rossner MJ
EMBO Mol Med; 2017 Oct; 9(10):1448-1462. PubMed ID: 28743784
[TBL] [Abstract][Full Text] [Related]
2. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
3. Hyperactivity is a Core Endophenotype of Elevated Neuregulin-1 Signaling in Embryonic Glutamatergic Networks.
Götze T; Soto-Bernardini MC; Zhang M; Mießner H; Linhoff L; Brzózka MM; Velanac V; Dullin C; Ramos-Gomes F; Peng M; Husseini H; Schifferdecker E; Fledrich R; Sereda MW; Willig K; Alves F; Rossner MJ; Nave KA; Zhang W; Schwab MH
Schizophr Bull; 2021 Aug; 47(5):1409-1420. PubMed ID: 33871014
[TBL] [Abstract][Full Text] [Related]
4. Sub-chronic Antipsychotic Drug Administration Reverses the Expression of Neuregulin 1 and ErbB4 in a Cultured MK801-Induced Mouse Primary Hippocampal Neuron or a Neurodevelopmental Schizophrenia Model.
Li C; Tang Y; Yang J; Zhang X; Liu Y; Tang A
Neurochem Res; 2016 Aug; 41(8):2049-64. PubMed ID: 27097547
[TBL] [Abstract][Full Text] [Related]
5. Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice.
Marchisella E; Wijnands R; Koopmans B; Spijker S; Loos M
Genes Brain Behav; 2018 Jan; 17(1):56-69. PubMed ID: 28792672
[TBL] [Abstract][Full Text] [Related]
6. Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Hasan A; Roeh A; Leucht S; Langguth B; Hansbauer M; Oviedo-Salcedo T; Kirchner SK; Papazova I; Löhrs L; Wagner E; Maurus I; Strube W; Rossner MJ; Wehr MC; Bauer I; Heres S; Leucht C; Kreuzer PM; Zimmermann S; Schneider-Axmann T; Görlitz T; Karch S; Egert-Schwender S; Schossow B; Rothe P; Falkai P
Contemp Clin Trials Commun; 2020 Mar; 17():100537. PubMed ID: 32072071
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin 1-ErbB4 signaling in the bed nucleus of the stria terminalis regulates anxiety-like behavior.
Geng F; Zhang J; Wu JL; Zou WJ; Liang ZP; Bi LL; Liu JH; Kong Y; Huang CQ; Li XW; Yang JM; Gao TM
Neuroscience; 2016 Aug; 329():182-92. PubMed ID: 27189883
[TBL] [Abstract][Full Text] [Related]
8. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.
Hahn CG; Wang HY; Cho DS; Talbot K; Gur RE; Berrettini WH; Bakshi K; Kamins J; Borgmann-Winter KE; Siegel SJ; Gallop RJ; Arnold SE
Nat Med; 2006 Jul; 12(7):824-8. PubMed ID: 16767099
[TBL] [Abstract][Full Text] [Related]
9. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice.
Savonenko AV; Melnikova T; Laird FM; Stewart KA; Price DL; Wong PC
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5585-90. PubMed ID: 18385378
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
11. Down-Regulation of Neuregulin1/ErbB4 Signaling in the Hippocampus Is Critical for Learning and Memory.
Tian J; Geng F; Gao F; Chen YH; Liu JH; Wu JL; Lan YJ; Zeng YN; Li XW; Yang JM; Gao TM
Mol Neurobiol; 2017 Aug; 54(6):3976-3987. PubMed ID: 27295274
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin 1/ErbB4 enhances synchronized oscillations of prefrontal cortex neurons via inhibitory synapses.
Hou XJ; Ni KM; Yang JM; Li XM
Neuroscience; 2014 Mar; 261():107-17. PubMed ID: 24374327
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation-Induced Downregulation of Hippocampacal Neuregulin 1-ErbB4 Signaling in the Parvalbumin Interneurons Might Contribute to Cognitive Impairment in a Mouse Model of Sepsis-Associated Encephalopathy.
Gao R; Ji MH; Gao DP; Yang RH; Zhang SG; Yang JJ; Shen JC
Inflammation; 2017 Apr; 40(2):387-400. PubMed ID: 27913953
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.
Bjarnadottir M; Misner DL; Haverfield-Gross S; Bruun S; Helgason VG; Stefansson H; Sigmundsson A; Firth DR; Nielsen B; Stefansdottir R; Novak TJ; Stefansson K; Gurney ME; Andresson T
J Neurosci; 2007 Apr; 27(17):4519-29. PubMed ID: 17460065
[TBL] [Abstract][Full Text] [Related]
15. NRG1-ErbB4 signaling promotes functional recovery in a murine model of traumatic brain injury via regulation of GABA release.
Deng W; Luo F; Li BM; Mei L
Exp Brain Res; 2019 Dec; 237(12):3351-3362. PubMed ID: 31720762
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice.
Dominguez SL; Hegde GV; Hanson JE; Xiang H; Mandikian D; Boswell CA; Chiu C; Wu Y; Tsai SP; Fleck D; Weber M; Ngu H; Scearce-Levie K; Jackson EL
Sci Rep; 2018 May; 8(1):8239. PubMed ID: 29844389
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.
Pan B; Huang XF; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):924-30. PubMed ID: 21513767
[TBL] [Abstract][Full Text] [Related]
18. Nrg1 haploinsufficiency alters inhibitory cortical circuits.
Navarro-Gonzalez C; Carceller H; Benito Vicente M; Serra I; Navarrete M; Domínguez-Canterla Y; Rodríguez-Prieto Á; González-Manteiga A; Fazzari P
Neurobiol Dis; 2021 Sep; 157():105442. PubMed ID: 34246770
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin 1 and ErbB4 Kinase Actively Regulate Sharp Wave Ripples in the Hippocampus.
Robinson HL; Tan Z; Santiago-Marrero I; Arzola EP; Dong TV; Xiong WC; Mei L
J Neurosci; 2022 Jan; 42(3):390-404. PubMed ID: 34844988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
